VF
IMCR icon

Virtu Financial’s Immunocore IMCR Stock Holding History

Virtu Financial’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$539K Buy
+16,968
New +$502K 0.02% 506
2025
Q3 		– Sell
-15,032
Closed -$472K – 1751
2025
Q2 		$472K Buy
+15,032
New +$467K 0.02% 592
2023
Q2 		– Sell
-10,029
Closed -$496K – 1740
2023
Q1 		$496K Buy
+10,029
New +$564K 0.05% 352

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Virtu Financial's IMCR Position: Q2 2026 in Review

Virtu Financial opened a new position in Immunocore (IMCR) in Q2 2026: 16,968 shares worth $539K. The stake represents 0.02% of the portfolio and ranks #506 among its holdings. This is a return to the name: Virtu Financial previously reported a position in IMCR as recently as Q2 2025.

Virtu Financial first reported a position in IMCR in Q1 2023 and has held it in 3 quarters since. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Virtu Financial held 16,968 shares of Immunocore worth $539K as of Q2 2026.
  • Immunocore was a new Virtu Financial position in Q2 2026.
  • Immunocore made up 0.02% of Virtu Financial's portfolio in Q2 2026, its #506 holding.
  • Virtu Financial first reported a position in Immunocore in Q1 2023 and has held it in 3 quarters since.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.